Dose-response relationships for late radiation effects in the head and neck: Regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577- 588; 1995

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 2, 1996, Pages 523-524

  Bentzen, S M ^a   Thames, H D ^a   Fu, K K ^a   Cox, J D ^a   Pajak, T F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; LETTER; MUCOSA INFLAMMATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030034298     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(96)82996-8     Document Type: Letter

References (13)

1. S.M. Bentzen Radiobiological considerations in the design of clinical trials Radiother. Oncol. 32 1994 1 11
2. S.M. Bentzen J. Overgaard Clinical normal-tissue radiobiology J.S. Tobias P.R.M. Thomas Current Radiation Oncology Vol. 2 1995 Amold London 37 67
3. Bentzen, S. M.; Ruifrok, A. C.; Thames, H. D. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time-interval between multiple fractions per day in radiotherapy. Radiother. Oncol. (submitted).
4. J.D. Cox T.F. Pajak V.A. Marcial L. Coia M. Mohiuddin K.K. Fu H. Selim P. Rubin H. Ortiz ASTRO plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group protocol 8313 Int. J. Radiat. Oncol. Biol. Phys. 20 1991 1191 1195
5. K.K. Fu T.F. Pajak V.A. Marcial H.G. Ortiz M. Rotman S.O. Asbell L.R. Coia N.L. Vora R. Byhardt P. Rubin S.D. Sorgen J.D. Cox J. Stetz Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13 Int. J. Radiat. Oncol. Biol. Phys. 32 1995 577 588
6. R. Guttenberger H.D. Thames K.K. Ang Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations Radiother. Oncol. 25 1992 280 286
7. T. Herrmann Späteffekte der hyperfraktionierten Strahlentherapie bei ausgedehnten HNO-Geschwülsten: Lagzeitresultate der RTOG-Studie 83-13 Strahlenther. Onkol. 171 1995 241 248
8. V.A. Marcial T.F. Pajak C. Chang L. Tupchong J. Stetz Hyperfractionated photon irradiation in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (Preliminary report) by the Radiation Therapy Oncology Group (RTOG) Int. J. Radiat. Oncol. Biol. Phys. 13 1985 41 47
9. H.D. Thames An ‘incomplete repair’ model for survival after fractionated and continuous irradiations Int. J. Radiat. Biol. 47 1985 319 339
10. H.D. Thames S.M. Bentzen I. Turesson M. Overgaard W. van den Bogaert Time-dose factors in radiotherapy: a review of the human data Radiother. Oncol. 19 1990 219 235
11. I. Turesson Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity Radiother. Oncol. 20 1991 149 158
12. H.R. Withers J.M.G. Taylor Interfraction interval and doseresponse in RTOG trials—Regarding Fu et al IJROBP 32 1995 577 588
13. H.R. Withers J.M.G. Taylor Int. J. Radiat. Oncol. Biol. Phys. 32 1995 887 888